도서명: | The Liver - Biology And Pathobiology ,6/e |
---|---|
정 가: | |
판매가: | 465,500원 |
적립금: | 9,310원 (2%) |
저 자: | Irwin M. Arias |
출판사: | Wiley |
ISBN : | 9781119436829 |
출판일: | 2020.01 |
판 형: | Hardcover |
수량: | |
판 수: | 6/e |
면 수: | 1144 page |
해외주문도서: | 해외 및 국내 입고 사정에 따라 2~4주 이상 소요될 수 있으며 - 해외주문은 취소 및 반품이 불가합니다. |
배송방법: | 택배 |
배송비: | 2,500원 (30,000원 이상 구매 시 무료) |
구매안내: | 네이버페이로 구매할 수 없는 상품입니다. |
배송주기
옵션선택 |
(최소주문수량 1개 이상 / 최대주문수량 0개 이하)
사이즈 가이드수량을 선택해주세요.
위 옵션선택 박스를 선택하시면 아래에 상품이 추가됩니다.
상품명 | 상품수 | 가격 |
---|---|---|
The Liver - Biology And Pathobiology ,6/e | ( 9310) |
할인가가 적용된 최종 결제예정금액은 주문 시 확인할 수 있습니다.
의학서적전문 "성보의학서적"의 신간의학도서입니다.
Bridging the gap between basic scientific advances and the understanding of liver disease — the extensively revised new edition of the premier text in the field.
The latest edition of The Liver: Biology and Pathobiology remains a definitive volume in the field of hepatology, relating advances in biomedical sciences and engineering to understanding of liver structure, function, and disease pathology and treatment. Contributions from leading researchers examine the cell biology of the liver, the pathobiology of liver disease, the liver’s growth, regeneration, metabolic functions, and more.
Now in its sixth edition, this classic text has been exhaustively revised to reflect new discoveries in biology and their influence on diagnosing, managing, and preventing liver disease. Seventy new chapters — including substantial original sections on liver cancer and groundbreaking advances that will have significant impact on hepatology — provide comprehensive, fully up-to-date coverage of both the current state and future direction of hepatology. Topics include liver RNA structure and function, gene editing, single-cell and single-molecule genomic analyses, the molecular biology of hepatitis, drug interactions and engineered drug design, and liver disease mechanisms and therapies. Edited by globally-recognized experts in the field, this authoritative volume:
•Relates molecular physiology to understanding disease pathology and treatment
•Links the science and pathology of the liver to practical clinical applications
•Features 16 new “Horizons” chapters that explore new and emerging science and technology
•Includes plentiful full-color illustrations and figures
The Liver: Biology and Pathobiology, Sixth Edition is an indispensable resource for practicing and trainee hepatologists, gastroenterologists, hepatobiliary and liver transplant surgeons, and researchers and scientists in areas including hepatology, cell and molecular biology, virology, and drug metabolism.
-도서목차-
List of Contributors x
Preface xx
Acknowledgments xxi
Part One: Introduction 1
1 Organizational Principles of the Liver 3
Peter Nagy, Snorri S. Thorgeirsson, and Joe W. Grisham
2 Embryonic Development of the Liver 14
Kenneth S. Zaret, Roque Bort, and Stephen A. Duncan
Part Two: The Cells 23
Section A: Cell Biology of the Liver 25
3 Cytoskeletal Motors: Structure and Function in Hepatocytes 27
Mukesh Kumar, Arnab Gupta, and Roop Mallik
4 Hepatocyte Surface Polarity 36
Anne Müsch and Irwin M. Arias
5 Primary Cilia 50
Carolyn M. Ott
6 Endocytosis in Liver Function and Pathology 62
Micah B. Schott, Barbara Schroeder, and Mark A. McNiven
7 The Hepatocellular Secretory Pathway 75
Catherine L. Jackson and Mark A. McNiven
8 Mitochondrial Function, Dynamics, and Quality Control 86
Marc Liesa, Ilan Benador, Nathanael Miller, and Orian S. Shirihai
9 Nuclear Pore Complex 94
Michelle A. Veronin and Joseph S. Glavy
10 Protein Maturation and Processing at the Endoplasmic Reticulum 108
Ramanujan S. Hegde
11 Protein Degradation and the Lysosomal System 122
Susmita Kaushik and Ana Maria Cuervo
12 Peroxisome Assembly, Degradation, and Disease 137
Rong Hua and Peter K. Kim
13 Organelle–Organelle Contacts: Origins and Functions 151
Uri Manor
14 Gap and Tight Junctions in Liver: Structure, Function, and Pathology 160
John W. Murray and David C. Spray
15 Ribosome Biogenesis and its Role in Cell Growth and Proliferation in the Liver 174
Katherine I. Farley‐Barnes and Susan J. Baserga
16 miRNAs and Hepatocellular Carcinoma 183
Yusuke Yamamoto, Isaku Kohama, and Takahiro Ochiya
17 Hepatocyte Apoptosis: Mechanisms and Relevance in Liver Diseases 195
Harmeet Malhi and Gregory J. Gores
Section B: The Hepatocyte 207
18 Copper Metabolism and the Liver 209
Cynthia Abou Zeid, Ling Yi, and Stephen G. Kaler
19 The Central Role of the Liver in Iron Storage and Regulation of Systemic Iron Homeostasis 215
Tracey A. Rouault, Victor R. Gordeuk, and Gregory J. Anderson
20 Disorders of Bilirubin Metabolism 229
Namita Roy Chowdhury, Yanfeng Li, and Jayanta Roy Chowdhury
21 Hepatic Lipid Droplets in Liver Function and Disease 245
Douglas G. Mashek, Wenqi Cui, Linshan Shang, and Charles P. Najt
22 Lipoprotein Metabolism and Cholesterol Balance 255
Mariana Acuña‐Aravena and David E. Cohen
Section C: Transporters, Bile Acids, and Cholestasis 269
23 Bile Acid Metabolism in Health and Disease: An Update 271
Tiangang Li and John Y.L. Chiang
24 TGR5 (GPBAR1) in the Liver 286
Verena Keitel, Christoph G.W. Gertzen, Lina Spomer, Holger Gohlke, and Dieter Häussinger
25 Bile Acids as Signaling Molecules 299
Thierry Claudel and Michael Trauner
26 Hepatic Adenosine Triphosphate‐Binding Cassette Transport Proteins and Their Role in Physiology 313
Peter L.M. Jansen
27 Basolateral Plasma Membrane Organic Anion Transporters 327
M. Sawkat Anwer and Allan W. Wolkoff
28 Hepatic Nuclear Receptors 337
Raymond E. Soccio
29 Molecular Cholestasis 351
Paul Gissen and Richard J. Thompson
30 Pathophysiologic Basis for Alternative Therapies for Cholestasis 364
Claudia D. Fuchs, Emina Halilbasic, and Michael Trauner
31 Adaptive Regulation of Hepatocyte Transporters in Cholestasis 378
James L. Boyer
Section D: Non‐Hepatocyte Cells 391
32 Cholangiocyte Biology and Pathobiology 393
Massimiliano Cadamuro, Romina Fiorotto, and Mario Strazzabosco
33 Polycystic Liver Diseases: Genetics, Mechanisms, and Therapies 408
Tatyana Masyuk, Anatoliy Masyuk, and Nicholas LaRusso
34 The Liver Sinusoidal Endothelial Cell: Basic Biology and Pathobiology 422
Karen K. Sørensen and Bård Smedsrød
35 Fenestrations in the Liver Sinusoidal Endothelial Cell 435
Victoria C. Cogger, Nicholas J. Hunt, and David G. Le Couteur
36 Stellate Cells and Fibrosis 444
Youngmin A. Lee and Scott L. Friedman
Part Three: Functions of The Liver 455
Section A: Metabolic Functions 457
37 Non‐alcoholic Fatty Liver Disease and Insulin Resistance 459
Max C. Petersen, Varman T. Samuel, Kitt Falk Petersen, and Gerald I. Shulman
38 AMPK: Central Regulator of Glucose and Lipid Metabolism and Target of Type 2 Diabetes Therapeutics 472
Daniel Garcia, Maria M. Mihaylova, and Reuben J. Shaw
39 Insulin‐Mediated PI3K and AKT Signaling 485
Hyokjoon Kwon and Jeffrey E. Pessin
40 Ca2+ Signaling in the Liver 496
Mateus T. Guerra, M. Fatima Leite, and Michael H. Nathanson
41 Clinical Genomics of NAFLD 509
Frank Lammert
Section B: Liver Growth and Regeneration 521
42 Stem Cell‐Fueled Maturational Lineages in Hepatic and Pancreatic Organogenesis 523
Wecheng Zhang, Amanda Allen, Eliane Wauthier, Xianwen Yi, Homayoun Hani, Praveen Sethupathy, David Gerber, Vincenzo Cardinale, Guido Carpino, Juan Dominguez‐Bendala, Giacomo Lanzoni, Domenico Alvaro, Eugenio Gaudio, and Lola Reid
43 Developmental Morphogens and Adult Liver Repair 539
Mariana Verdelho Machado and Anna Mae Diehl
44 Liver Repopulation by Cell Transplantation and the Role of Stem Cells in Liver Biology 550
David A. Shafritz and Markus Grompe
45 Liver Regeneration 566
George K. Michalopoulos
46 β‐Catenin Signaling 585
Satdarshan P.S. Monga
47 Polyploidy in Liver Function, Mitochondrial Metabolism, and Cancer 603
Evan R. Delgado, Elizabeth C. Stahl, Nairita Roy, Patrick D. Wilkinson, and Andrew W. Duncan
Part Four: Pathobiology of Liver Disease 615
48 Hepatic Encephalopathy 617
Roger F. Butterworth
49 The Kidney in Liver Disease 630
Moshe Levi, Shogo Takahashi, Xiaoxin X. Wang, and Marilyn E. Levi
50 α1‐Antitrypsin Deficiency 645
David A. Rudnick and David H. Perlmutter
51 Pathophysiology of Portal Hypertension 659
Yasuko Iwakiri and Roberto J. Groszmann
52 Non‐alcoholic Fatty Liver Disease: Mechanisms and Treatment 670
Yaron Rotman and Devika Kapuria
53 Alcoholic Liver Disease 682
Bin Gao, Xiaogang Xiang, Lorenzo Leggio, and George F. Koob
54 Drug‐Induced Liver Injury 701
Lily Dara and Neil Kaplowitz
55 Oxidative Stress and Inflammation in the Liver 714
John J. Lemasters and Hartmut Jaeschke
56 The Role of Bile Acid‐Mediated Inflammation in Cholestatic Liver Injury 728
Shi‐Ying Cai, Man Li, and James L. Boyer
57 Toll‐like Receptors in Liver Disease 737
So Yeon Kim and Ekihiro Seki
Part Five: Liver Cancer 747
58 Experimental Models of Liver Cancer: Genomic Assessment of Experimental Models 749
Sun Young Yim, Jae‐Jun Shim, Bo Hwa Sohn, and Ju‐Seog Lee
59 Epidemiology of Hepatocellular Carcinoma 758
Hashem B. El‐Serag
60 Mutations and Genomic Alterations in Liver Cancer 773
Jessica Zucman‐Rossi and Jean‐Charles Nault
61 Treatment of Liver Cancer 782
Tim F. Greten
Part Six: Hepatitis 793
62 Molecular Biology of Hepatitis Viruses 795
Christoph Seeger, William S. Mason, and Michael M.C. Lai
63 Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis 821
Carlo Ferrari, Valeria Barili, Stefania Varchetta, and Mario U. Mondelli
64 Clinical Implications of the Molecular Biology of Hepatitis B Virus 851
Timothy M. Block, Ju‐Tao Guo, and W. Thomas London
65 Viral Escape Mechanisms in Hepatitis C and the Clinical Consequences of Persistent Infection 868
Marc G. Ghany, Christopher M. Walker, and Patrizia Farci
66 Tracking Hepatitis C Virus Interactions with the Hepatic Lipid Metabolism : A Hitchhiker’s Guide to Solve Remaining Translational Research Challenges in Hepatitis C 889
Gabrielle Vieyres and Thomas Pietschmann
67 Nucleoside Antiviral Agents for HCV: What’s Left to Do? 906
Franck Amblard, Seema Mengshetti, Junxing Shi, Sijia Tao, Leda Bassit, and Raymond F. Schinazi
68 Hepatitis E Virus: An Emerging Zoonotic Virus Causing Acute and Chronic Liver Disease 915
Xiang‐Jin Meng
69 Biological Principles and Clinical Issues Underlying Liver Transplantation for Viral‐Induced End‐Stage Liver Disease in the Era of Highly Effective Direct‐Acting Antiviral Agents 926
Michael S. Kriss, James R. Burton, Jr., and Hugo R. Rosen
70 Time for the Elimination of Hepatitis C Virus as a Global Health Threat 935
John W. Ward, Alan R. Hinman, and Harvey J. Alter
Part Seven: Horizons 953
71 Genome Editing by Targeted Nucleases and the CRISPR/Cas Revolution 955
Shawn M. Burgess
72 Imaging Cellular Proteins and Structures: Smaller, Brighter, and Faster 965
Aubrey V. Weigel and Erik Lee Snapp
73 Liver‐Directed Gene Therapy 979
Patrik Asp, Chandan Guha, Namita Roy Chowdhury, and Jayanta Roy Chowdhury
74 Telomeres and Telomerase in Liver Generation and Cirrhosis 992
Sonja C. Schätzlein and K. Lenhard Rudolph
75 Toxins and Biliary Atresia 1000
Michael Pack and Rebecca G. Wells
76 The Dual Role of ABC Transporters in Drug Metabolism and Resistance to Chemotherapy 1007
Jean‐Pierre Gillet, Marielle Boonen, Michel Jadot, and Michael M. Gottesman
77 Stem Cell‐Derived Liver Cells: From Model System to Therapy 1015
Helmuth Gehart and Hans Clevers
78 Extracellular Vesicles and Exosomes: Biology and Pathobiology 1022
Gyongyi Szabo and Fatemeh Momen‐Heravi
79 Integrated Technologies for Liver Tissue Engineering 1028
Tiffany N. Vo, Amanda X. Chen, Quinton B. Smith, Arnav Chhabra and Sangeeta N. Bhatia
80 Pluripotent Stem Cells and Reprogramming: Promise for Therapy 1036
James A. Heslop and Stephen A. Duncan
81 Chromatin Regulation and Transcription Factor Cooperation in Liver Cells 1043
Ido Goldstein
82 Drug Interactions in the Liver 1050
Guruprasad P. Aithal and Gerd A. Kullak‐Ublick
83 Metabolic Regulation of Hepatic Growth 1058
Wolfram Goessling
84 The Gut Microbiome and Liver Disease 1062
Lexing Yu, Jasmohan S. Bajaj, and Robert F. Schwabe
85 Lineage Tracing: Efficient Tools to Determine the Fate of Hepatic Cells in Health and Disease 1069
Frédéric Lemaigre
86 The Hepatocyte as a Household for Plasmodium Parasites 1075
Vanessa Zuzarte‐Luis and Maria M. Mota
Index 1081
기타 의학도서에 관련된 문의사항은 고객센터(02-854-2738) 또는 저희 성보의학서적 홈페이지내 도서문의 게시판에 문의바랍니다.
감사합니다.
성보의학서적 "http://www.medcore.kr
고액결제의 경우 안전을 위해 카드사에서 확인전화를 드릴 수도 있습니다.
확인과정에서 도난 카드의 사용이나 타인 명의의 주문등 정상적인 주문이 아니라고 판단될 경우 임의로 주문을 보류 또는 취소할 수 있습니다.
무통장 입금은 상품 구매 대금은 PC뱅킹, 인터넷뱅킹, 텔레뱅킹 혹은 가까운 은행에서 직접 입금하시면 됩니다.
주문시 입력한 입금자명과 실제입금자의 성명이 반드시 일치하여야 하며, 3일 이내로 입금을 하셔야 하며 입금되지 않은 주문은 자동취소 됩니다.
고객님께서 저희 성보의학서적에서 주문을 하신 주문번호가 생성이 되면 그에 따른 발송준비 및 배송절차는 다음과 같습니다
- 일반적으로 배송기간은 입금확인일로부터 3일 이내 배송을 원칙으로 합니다. 이는 재고가 확보된 도서의 경우입니다.
(단, 산간이나 지방 및 도서지역의 경우 약 1~2일이 더 소요될 수 있습니다.)
- 배송의 시점은 고객님의 주문 이후 입금확인 과정을 거쳐 배송이 됩니다.
- 주문도서의 배송 시 휴일이 포함된 경우는 24시간 순연됩니다.
- 배송료는 회원주문, 비회원주문 모두 2,500원 입니다. (일부 도서 및 산간지역은 추가 배송비 발생)
- 주문 금액이 30,000원 이상일 경우에는 무료로 배송해 드립니다.
- 반품/취소.환불 시 배송비는 무료로 배송이 되었을 경우, 처음 발생한 배송비까지 소급 적용될 수 있으며,
상품 하자로 인한 도서 교환시에는 무료로 가능합니다.
- 성보의학서적의 기본배송방법으로 택배서비스(한진택배&우체국)를 이용합니다.
해외원서의 경우
- 국내에서 재고를 보유한 업체가 없는 경우 해외주문을 해야 하는 상황이 생깁니다.
이 경우 4~5주 안에 공급이 가능하며 현지 출판사 사정에 따라 구입이 어려운 경우 2~3주 안에 공지해 드립니다.
- 재고 유무는 주문 전 사이트 상에서 배송 안내 문구로 구분 가능하며, 필요에 따라 전화 문의 주시면 거래처를 통해
다시 한번 국내재고를 확인해 드립니다.
- 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
- 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.
반품안내
전자상거래에 의한 소비자보호에 관한 법률에 의거 반품 가능 기간내에는 반품을 요청하실 수 있습니다.
반품가능기간
- 단순변심 : 물품 수령 후 14일 이내 (단, 고객님의 요청으로 주문된 해외원서 제외)
- 주문하신 것과 다른 상품을 받으신 경우
- 파본인 상품을 받으신 경우- 개봉된 DVD, CD-ROM, 카세트테이프 (단, 배송 중 파손된 상품 제외)
- 탐독의 흔적이 있는 경우
- 소비자의 실수로 상품이 훼손된 경우
- 고객님의 주문으로 수입된 해외 도서인 경우
- 수령일로 14일 지난 상품의 경우
고객센터: (02)854-2738